VANGUARD GROUP INC 13D and 13G filings for Corcept Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:02 pm Sale | 2023-12-29 | 13G | Corcept Therapeutics Incorporated CORT | VANGUARD GROUP INC | 9,537,532 9.250% | -807,498 (-7.81%) | Filing |
| 2023-02-09 11:15 am Sale | 2022-12-30 | 13G | Corcept Therapeutics Incorporated CORT | VANGUARD GROUP INC | 10,345,030 9.610% | -499,759 (-4.61%) | Filing |
| 2022-03-09 08:44 am Purchase | 2022-02-28 | 13G | Corcept Therapeutics Incorporated CORT | VANGUARD GROUP INC | 10,844,789 10.230% | 47,312 (+0.44%) | Filing |
| 2022-02-09 3:43 pm Sale | 2021-12-31 | 13G | Corcept Therapeutics Incorporated CORT | VANGUARD GROUP INC | 10,797,477 9.350% | -1,198,672 (-9.99%) | Filing |
| 2021-02-10 10:46 am Purchase | 2020-12-31 | 13G | Corcept Therapeutics Incorporated CORT | VANGUARD GROUP INC | 11,996,149 10.330% | 264,345 (+2.25%) | Filing |